SCHEMBL24728992

SCHEMBL24728992

COC(=O)C1(c2cn(C(=O)OC(C)(C)C)c3ccccc23)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.48
ACHE P22303 1/20 0.43
BRD4 O60885 1/20 0.43
CREBBP Q92793 1/20 0.43
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
PIM1 P11309 1/20 0.43
MARK3 P27448 1/20 0.43
MAP4K2 Q12851 1/20 0.43
CAMK2B Q13554 1/20 0.43
PIM3 Q86V86 1/20 0.43
PIM2 Q9P1W9 1/20 0.43
EPHX1 P07099 1/20 0.42
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
PDE10A Q9Y233 1/20 0.39
HTR6 P50406 2/20 0.37
ADAM17 P78536 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22864575 0.85 HTR6 (0.40) L3MBTL1ACHEBRD4CREBBPKMT2A
SCHEMBL999150 0.79 L3MBTL1 (0.48) L3MBTL1ACHEBRD4CREBBPKMT2A
SCHEMBL30912193 0.77 L3MBTL1 (0.50) L3MBTL1ACHEBRD4CREBBPKMT2A
SCHEMBL23629399 0.77 L3MBTL1 (0.50) L3MBTL1ACHEBRD4CREBBPKMT2A
SCHEMBL29374710 0.75 L3MBTL1 (0.57) L3MBTL1ACHEBRD4CREBBPKMT2A
SCHEMBL1055676 0.75 L3MBTL1 (0.57) L3MBTL1ACHEBRD4CREBBPKMT2A
SCHEMBL1746797 0.75 KMT2A (0.76) L3MBTL1KMT2AMEN1KDM4EALDH1A1
SCHEMBL29651126 0.75 KMT2A (0.76) L3MBTL1KMT2AMEN1KDM4EALDH1A1
SCHEMBL29226891 0.74 CCNB2 (0.41) L3MBTL1ACHEBRD4CREBBPPIM1
SCHEMBL1196430 0.74 L3MBTL1 (0.59) L3MBTL1ACHEBRD4CREBBPKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220389037-A1 HPK1 INHIBITORS AND USES THEREOF REGOR PHARMACEUTICALS, INC. 2022-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220389037-A1 HPK1 INHIBITORS AND USES THEREOF HIPK1, SIK1, PGK1 L3MBTL1 2199/4885ACHE 4818/4885BRD4 2999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.